| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| AMTD International (TBA) | AMTD Global Markets/ Tiger Brokers | $200.00 | n.a. | |||
| Fulcrum Therapeutics (FULC) | Morgan Stanley/ BofA Merrill Lynch/ SVB Leerink | $86.25 | n.a. | |||
| LMP Automotive Holdings (LMPX) | ThinkEquity (a division of Fordham Financial Management) | 1.28 | $5.00 | $6.00 | $7.01 | n.a. |
| Medallia (MDLA) | BofA Merrill Lynch/ Citigroup/ Wells Fargo Securities/ Credit Suisse | $100.00 | n.a. | |||
| Mirum Pharmaceuticals (MIRM) | Citigroup/ Evercore ISI/ Guggenheim Securities | $86.26 | n.a. | |||
| Phreesia (PHR) | J.P. Morgan/ Wells Fargo Securities/ William Blair/ Allen & Company/ Piper Jaffray | $125.00 | n.a. | |||
| SC Health (SCH.U (u) | Credit Suisse | 15.00 | $10.00 | $10.00 | $150.00 | n.a. |
| Tuscan Holdings Corp. II (THCAU) (u) | EarlyBirdCapital | 1.25 | $10.00 | $10.00 | $12.50 | n.a. |
| n.a. (not available) | ||||||
| TBA (to be announced) | ||||||
| u = unit offering | ||||||
| Postponed | ||||||
| Dermavant Sciences (DRMT) | Jefferies/ SVB Leerink/ Guggenheim Securities | 7.70 | $12.00 | $14.00 | $100.10 | S/O |
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Adaptive Biotechnologies (ADPT) | Goldman Sachs/ J.P. Morgan/ BofA Merrill Lynch | 12.50 | $15.00 | $17.00 | $200.00 | S/O |
| BlackRock Science and Technology Trust II (BSTZ) | Morgan Stanley/ BofA Merrill Lynch/ UBS Investment Bank/ Wells Fargo Securities/ Raymond James | 50.00 | $20.00 | $20.00 | $1,000.00 | S/O |
| BridgeBio Pharma (BBIO) | J.P. Morgan/ Goldman Sachs/ Jefferies/ SVB Leerink/ KKR/ Piper Jaffray/ Mizuho Securities/ BMO Capital Markets/ Raymond James | 15.00 | $14.00 | $16.00 | $225.00 | S/O |
| Karuna Therapeutics (KRTX) | Goldman Sachs/ Citigroup/ Wells Fargo Securities | 4.38 | $15.00 | $17.00 | $70.00 | S/O |
| Priam Properties (PRIM) | BofA Merrill Lynch/ Baird/ RBC Capital Markets/ Stifel | 9.00 | $18.00 | $20.00 | $171.00 | S/O |
| SolarMax Technology (SMXT) | ViewTrade Securities | 4.00 | $4.00 | $4.00 | $16.00 | S/O |
| The RealReal (REAL) | Credit Suisse/ BofA Merrill Lynch/ UBS Investment Bank | 15.00 | $17.00 | $19.00 | $270.00 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of June 17, 2019 | Manager(s) | Offered | Raised | Price | 6/21/19 | Change |
| Personalis (PSNL) | Morgan Stanley/ BofA Merrill Lynch/ Cowen and Company | 7.92 | $134.67 | $17.00 | $30.25 | 77.94% |
| Stoke Therapeutics (STOK) | J.P. Morgan/ Cowen/ Credit Suisse | 6.70 | $120.60 | $18.00 | $27.29 | 51.61% |
| Grocery Outlet Holding (GO) | BofA Merrill Lynch/ Morgan Stanley/ Deutsche Bank Securities/ Jefferies/ Barclays/ Goldman Sachs/ Guggenheim Securities/ UBS Investment Bank/ Cowen | 17.19 | $378.13 | $22.00 | $28.60 | 30.00% |
| Akero Therapeutics (AKRO) | J.P. Morgan/ Jefferies/ Evercore ISI | 5.75 | $92.00 | $16.00 | $19.70 | 23.13% |
| Atreca (BCEL) | Cowen/ Evercore ISI/ Stifel | 7.35 | $124.95 | $17.00 | $17.07 | 0.41% |
| South Mountain Merger (SMMCU) (u) | Citigroup | 22.50 | $225.00 | $10.00 | $10.00 | 0.00% |
| Slack Technologies (WORK) | DPO (Direct Public Offering) | 118.43 | $4,559.54 | $38.50 | $37.22 | -3.32% |
| Prevail Therapeutics (PRVL) | Morgan Stanley/ BofA Merrill Lynch/ Cowen and Company | 7.35 | $125.00 | $17.00 | $14.50 | -14.71% |
| u (unit offering) | ||||||
